M. Drehobl
发表
A. Wald,
L. Corey,
M. Shahmanesh,
2006,
Vaccine.
M. Drehobl,
J. Guerrero,
P. R. Lacarte,
2008
.
J. Hedrick,
J. M. Rogers,
A. Hoberman,
1997,
The Pediatric infectious disease journal.
J. Bergan,
M. Drehobl,
W. Bundens,
1995,
JAMA.
M. De Salvo,
M. Drehobl,
Jeanne D. Breen,
2005,
Chest.
D. Hunninghake,
H. Schrott,
H. Schrott,
1998,
The Journal of family practice.
C. Munera,
M. Drehobl,
N. Sessler,
2010,
Journal of opioid management.
H. Bays,
M. Drehobl,
R. Knopp,
2001,
Clinical therapeutics.
Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
M. Drehobl,
M. Barker,
D. Maladorno,
1997,
Chemotherapy.
T. Bock,
F. Lucente,
M. Drehobl,
1999
.
M. Drehobl,
L. Eron,
W. Bushnell,
1998,
The Journal of family practice.
D. Stevens,
M. Drehobl,
F. Pien,
1993,
Diagnostic microbiology and infectious disease.
M. Drehobl,
S. Stool,
M. Toscani,
2000
.
M. Drehobl,
J. Guerrero,
P. R. Lacarte,
2008,
Current medical research and opinion.
M. Drehobl,
K. Tack,
C. Keyserling,
1997,
Antimicrobial agents and chemotherapy.
M. Drehobl,
J. McCarty,
R. Tosiello,
1998
.
H. Bays,
M. Drehobl,
R. Knopp,
2000
.
J. Schoenberger,
M. Drehobl,
G. Ruoff,
1995,
Antimicrobial agents and chemotherapy.
K. Jarvi,
J. Shapiro,
M. Seger,
2008,
The Journal of urology.
R. Jacobs,
P. Darden,
R. Yetman,
1992,
Antimicrobial Agents and Chemotherapy.
M. Drehobl,
J. McCarty,
R. Tosiello,
1998,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
J. Schoenberger,
M. Drehobl,
G. Ruoff,
1995,
Clinical therapeutics.